Defy the drug development odds for advancement of your small or large molecule with Covance, a global leader in bioanalytical services for over 30 years.
You have substantial personal and economic investment in your product and Covance understands the seemingly insurmountable challenges of early product development. Seize opportunities and insight with our thorough understanding of drug development strategies, processes and timelines coupled to Covance's world class service, expertise and efficiency to help you take the time and cost out of drug development.
Strategic outsourcing alliances are beneficial for you and deliver operational and service excellence in bioanalytical solutions by providing:
- Flexible global resources: Six global sites dedicated to bioanalytical services
- Clinical support: Central laboratory and clinical development services in 100+ countries
- Innovation drivers: Advancements in efficiency through science and technology
- Integrated services: Discovery through phase IV services
Small molecule LC-MS/MS
Gain high sensitivity and specificity with Covance's liquid chromatography-mass spectrometry (LC-MS/MS) bioanalytical services. LC-MS/MS is a powerful tool in the arsenal for drug developers, whether for pharmacokinetic analysis, or identification of key metabolites and impurities.
Expand your scientific and regulatory bioanalysis capability by choosing Covance for specialty services and rapid data delivery to expedite your decision making process.
- Over 1,900 years of cumulative industry experience in small molecule analysis
- Discovery through phase IV
- Cutting edge technology in automated and analytical instrumentation
Large molecule immunochemistry
Put a-30 year track record of success to work for you on a broad set of diverse product candidates and their associated biomarkers. Covance's dedicated, specialized research scientists use state-of-the art immunological and immunoassay techniques in our approach to work for you. You also gain a highly trained technical staff with integrated, flexible global resources to customize methods and services tailored to your needs.
Avail yourself to Covance's comprehensive range of techniques and processes for assessing critical parameters in the development of biologic therapeutic agents for both preclinical and clinical trials. Techniques include:
- Electrochemiluminescence (ECL)
- Surface plasma resonance
- Radioimmunoassay (RIA)
With access to both commercially available reagents and custom made polyclonal and monoclonal antibodies, your Covance team develops novel assays and run kit-based assay systems in compliance with all regulatory requirements.